SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-14
👔
Eton Pharmaceuticals, Inc.
@ETON_InsiderForm 4 Filing: BRYNJELSEN SEAN Exercises Options for $274,000 of $ETON
OPTION EXERCISE
⚡ MATERIALITY: 5/10
corporate issuer
Eton Pharmaceuticals, Inc.
Ticker: $ETON
Transaction Value
$274,000
Price/Share: $1.20
transaction date
2026-07-14
Shares: 227,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BRYNJELSEN SEAN, holds the title of President & CEO at Eton Pharmaceuticals, Inc..
On 2026-07-14, the insider transacted 227,500 shares.The shares were transacted at a weighted average price of $1.20 per share, resulting in a total market-relevant value of $274,000.
Executive Summary Summary
BRYNJELSEN SEAN (President & CEO) exercised options for $274K of $ETON
Post-Transaction Position: 1,061,194 shares
SEC Accession No: 0001437749-26-023570 (CIK: 1669976)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.